サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1553553

被覆ステントの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年

Covered Stent Market Size, Share & Trends Analysis Report By Product (Vascular Stent, Non-vascular Stent), By End Use (Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
被覆ステントの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年08月21日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

被覆ステントの市場規模と動向：

世界の被覆ステント市場規模は2023年に11億3,000万米ドルと推定され、2024年から2030年にかけてCAGR 4.1％で成長すると予測されています。

この市場の成長を牽引しているのは、血管疾患の有病率の増加、被覆ステント技術の進歩、認知度と診断の向上、応用範囲と適応症の拡大です。2024年4月、米国心臓協会（American Heart Association, Inc.）は、1億1,600万人から2億3,000万人が罹患している下肢末梢動脈疾患（PAD）の世界の有病率が、被覆ステントの需要増加を促す主要因であると報告しました。この高い有病率は、効果的な血管インターベンションの緊急の必要性を強調しており、被覆ステントはPADを管理し、患者ケアを向上させるための重要なソリューションとして世界中で位置づけられています。

被覆ステントの技術的進歩が市場の成長を後押ししています。MDPIによる2023年2月の記事では、被覆ステントは現在、ポリテトラフルオロエチレン（PTFE）などの高度な生体適合性ポリマーで設計されていることが強調されています。これらの材料は組織の浸潤を防ぐバリアとして機能し、再狭窄のリスクを大幅に低減します。さらに、露出した炎症性表面を封鎖するのに特に効果的で、新生内膜過形成の発生を抑制するのに役立つと考えられます。

さらに2023年11月には、3Dプリンティング技術によって、個々の患者のユニークな解剖学的構造に合わせたパーソナライズド・カバード・ステントの作成に革命が起こりつつあります。このアプローチにより、寸法や機械的特性がカスタマイズされたステントの製造が可能になり、その性能と血管系内での統合性が向上します。さらに、最新世代の被覆ステントには薬剤溶出機能が組み込まれており、抗増殖薬の局所デリバリーを可能にして再狭窄のリスクをさらに軽減しています。現在進行中の調査では、治癒プロセスを最適化し合併症を最小限に抑えるために、複数の薬剤を順次放出する方法が研究されています。

被覆ステントの優れた有効性は市場成長の主要な促進要因です。Elsevier Ltd.が2024年4月に発表した論文では、慢性腸間膜虚血の治療におけるベアメタルステントに対する被覆ステントの優位性が強調されています。オランダの6施設で実施された研究では、被覆ステントの長期開存率が有意に優れており、ベアメタルステントではわずか49％であったのに対し、被覆ステントでは81％が24ヵ月時点で一次開存を維持していました。このような性能の向上は、被覆ステントに対する嗜好の高まりを裏付けるものであり、血管内治療における被覆ステントの採用に拍車をかけています。

認知度と診断の向上が市場成長を促進する主な要因です。2023年9月に発表されたイェール大学医学部の論文によると、9月は全国末梢動脈疾患（PAD）啓発月間に指定されています。このイニシアチブは、PADの危険因子、症状、早期診断の重要性について人々を教育することにより、PADに対する一般市民の意識を高めることを目的としています。この月間を通して、さまざまな団体が支援活動を行い、教材を提供し、リスクのある人に血管スクリーニングを受けるよう勧める。その第一の目的は、PADに伴う重篤な合併症を予防するための早期発見・早期治療の重要性を強調することです。

さらに、2021年3月に実施された国際調査では、各国におけるPADの認知度が評価され、参加者の57％がPADを知らなかったことが明らかになり、知識のギャップが大きく浮き彫りになった。この調査では、国や年齢層によって認知度に差があることも確認され、的を絞った啓発活動の必要性が浮き彫りになった。これらの知見は、ヘルスケア提供者や政策立案者が、PADの認知度における現在の欠点に対処するため、より効果的な教育キャンペーンを開発する際に役立つことを目的としています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の被覆ステント市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 被覆ステント市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 被覆ステント市場：製品別推定・動向分析

  • 被覆ステント市場：製品別ダッシュボード
  • 被覆ステント市場：製品変動分析
  • 被覆ステント市場規模と予測および動向分析、製品別、2018～2030年
  • 血管ステント
  • 非血管ステント

第5章 被覆ステント市場： 最終用途別推定・動向分析

  • 被覆ステント市場：最終用途別ダッシュボード
  • 被覆ステント市場：最終用途変動分析
  • 被覆ステント市場の規模と予測および動向分析、最終用途別、2018～2030年
  • 病院
  • 外来ケアセンター（ACS）
  • 専門クリニック

第6章 被覆ステント市場：国、製品、最終用途別の地域推定・動向分析

  • 世界の被覆ステント市場：地域別ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023年
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik SE &Co. KG
    • WL Gore &Associates, Inc.
    • Cook
    • Terumo Corporation
    • B. Braun Interventional Systems, Inc.
    • BD
    • Getinge
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global covered stent market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global covered stent market by end use, 2018 - 2030
  • Table 5 Global Covered Stent market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America covered stent market by country, 2018 - 2030 (USD Million)
  • Table 7 North America covered stent market by product, 2018 - 2030 (USD Million)
  • Table 8 North America covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S covered stent market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S covered stent market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada covered stent market by product, 2018 - 2030 (USD Million)
  • Table 12 Canada covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico covered stent market by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe covered stent market by country, 2018 - 2030 (USD Million)
  • Table 16 Europe covered stent market by product, 2018 - 2030 (USD Million)
  • Table 17 Europe covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 18 UK covered stent market by product, 2018 - 2030 (USD Million)
  • Table 19 UK covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany covered stent market by product, 2018 - 2030 (USD Million)
  • Table 21 Germany covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 22 France covered stent market by product, 2018 - 2030 (USD Million)
  • Table 23 France covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 24 Italy covered stent market by product, 2018 - 2030 (USD Million)
  • Table 25 Italy covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 26 Spain covered stent market by product, 2018 - 2030 (USD Million)
  • Table 27 Spain covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark covered stent market by product, 2018 - 2030 (USD Million)
  • Table 29 Denmark covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden covered stent market by product, 2018 - 2030 (USD Million)
  • Table 31 Sweden covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 32 Norway covered stent market by product, 2018 - 2030 (USD Million)
  • Table 33 Norway covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific covered stent market by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific covered stent market by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 37 Japan covered stent market by product, 2018 - 2030 (USD Million)
  • Table 38 Japan covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 39 China covered stent market by product, 2018 - 2030 (USD Million)
  • Table 40 China covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 41 India covered stent market by product, 2018 - 2030 (USD Million)
  • Table 42 India covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 43 Australia covered stent market by country, 2018 - 2030 (USD Million)
  • Table 44 Australia covered stent market by product, 2018 - 2030 (USD Million)
  • Table 45 Australia covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand covered stent market by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 48 South Korea covered stent market by product, 2018 - 2030 (USD Million)
  • Table 49 South Korea covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 50 Latin America covered stent market by country, 2018 - 2030 (USD Million)
  • Table 51 Latin America covered stent market by product, 2018 - 2030 (USD Million)
  • Table 52 Latin America covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 53 Brazil covered stent market by product, 2018 - 2030 (USD Million)
  • Table 54 Brazil covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 55 Argentina covered stent market by product, 2018 - 2030 (USD Million)
  • Table 56 Argentina covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 57 MEA covered stent market, by country, 2018 - 2030 (USD Million)
  • Table 58 MEA covered stent market by product, 2018 - 2030 (USD Million)
  • Table 59 MEA covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 60 South Africa covered stent market by product, 2018 - 2030 (USD Million)
  • Table 61 South Africa covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia covered stent market by product, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 64 UAE covered stent market by product, 2018 - 2030 (USD Million)
  • Table 65 UAE covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 66 Kuwait covered stent market by product, 2018 - 2030 (USD Million)
  • Table 67 Kuwait covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 68 Participant's overview
  • Table 69 Financial performance
  • Table 70 Key companies undergoing expansions
  • Table 71 Key companies undergoing acquisitions
  • Table 72 Key companies undergoing collaborations
  • Table 73 Key companies launching new products
  • Table 74 Key companies undergoing partnerships
  • Table 75 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Covered stent market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Covered stent market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's Five Forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Covered stent market Product outlook:
  • Fig. 14 Covered stent market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global vascular stent market, 2018 - 2030 (USD Million)
  • Fig. 17 Global non-vascular stent market, 2018 - 2030 (USD Million)
  • Fig. 18 Covered stent market end use outlook:
  • Fig. 19 Covered stent market: end use movement analysis
  • Fig. 20 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 21 Global ambulatory care centers market, 2018 - 2030 (USD Million)
  • Fig. 22 Global specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 23 Regional market place: Key takeaways
  • Fig. 24 North America covered stent market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S covered stent market, 2018 - 2030 (USD Million)
  • Fig. 26 Canada covered stent market, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico covered stent market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe covered stent market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany covered stent market, 2018 - 2030 (USD Million)
  • Fig. 30 UK covered stent market, 2018 - 2030 (USD Million)
  • Fig. 31 France covered stent market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy covered stent market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain covered stent market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific covered stent market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan covered stent market, 2018 - 2030 (USD Million)
  • Fig. 36 China covered stent market, 2018 - 2030 (USD Million)
  • Fig. 37 India covered stent market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia covered stent market, 2018 - 2030 (USD Million)
  • Fig. 39 Latin America covered stent market, 2018 - 2030 (USD Million)
  • Fig. 40 Brazil covered stent market, 2018 - 2030 (USD Million)
  • Fig. 41 MEA covered stent market, 2018 - 2030 (USD Million)
  • Fig. 42 South Africa covered stent market, 2018 - 2030 (USD Million)
  • Fig. 43 Saudi Arabia covered stent market, 2018 - 2030 (USD Million)
  • Fig. 44 Market Participant Categorization
  • Fig. 45 Strategy mapping
目次
Product Code: GVR-4-68040-421-3

Covered Stent Market Size & Trends:

The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. The market's growth is driven by the increasing prevalence of vascular diseases, advancements in covered stent technology, greater awareness and diagnosis, and the expanding range of applications and indications. In April 2024, the American Heart Association, Inc. reported that the global prevalence of lower extremity peripheral artery disease (PAD), affecting between 116 and 230 million people, is a major factor driving the increased demand for covered stents. This high prevalence underscores the urgent need for effective vascular interventions, positioning covered stents as a critical solution for managing PAD and enhancing patient care worldwide.

Technological advancements in covered stents are propelling the market growth. A February 2023 article by MDPI highlights that covered stents are now being designed with advanced biocompatible polymers, such as polytetrafluoroethylene (PTFE). These materials serve as barriers to prevent tissue ingrowth, significantly reducing the risk of restenosis. Additionally, they are particularly effective in sealing off exposed inflammatory surfaces, which may help inhibit the development of neointimal hyperplasia.

Moreover, in November 2023, 3D printing technology is revolutionizing the creation of personalized covered stents tailored to match the unique anatomical structures of individual patients. This approach allows the production of stents with customized dimensions and mechanical properties, improving their performance and integration within the vascular system. Furthermore, the latest generations of covered stents incorporate drug-eluting capabilities, enabling localized delivery of anti-proliferative drugs to mitigate the risk of restenosis further. Ongoing research is exploring the sequential release of multiple drugs to optimize healing processes and minimize complications.

The superior efficacy of covered stents is a key driver of market growth. An article published by Elsevier Ltd. in April 2024 highlights the advantages of covered stents over bare-metal stents in treating chronic mesenteric ischemia. A study conducted across six centers in the Netherlands found that covered stents had significantly better long-term patency, with 81% maintaining primary patency at 24 months, compared to just 49% for bare-metal stents. This enhanced performance underscores the increasing preference for covered stents, fueling their adoption in vascular procedures.

Increased awareness and diagnosis are key factors driving market growth. According to a Yale School of Medicine article published in September 2023, September has been designated as National Peripheral Artery Disease (PAD) Awareness Month. This initiative aims to raise public awareness about PAD by educating people on its risk factors, symptoms, and the importance of early diagnosis. Throughout the month, various organizations conduct outreach efforts, provide educational materials, and encourage at-risk individuals to undergo vascular screenings. The primary goal is to emphasize the importance of early detection and treatment to prevent serious complications associated with PAD.

Additionally, international surveys conducted in March 2021 assessed public awareness of PAD in various countries, revealing that 57% of participants were unfamiliar with the condition, highlighting a significant knowledge gap. The surveys also identified variations in awareness between countries and across age groups, underscoring the need for targeted awareness initiatives. These findings aim to assist healthcare providers and policymakers in developing more effective educational campaigns to address the current shortcomings in PAD awareness.

Global Covered Stent Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global covered stent market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Vascular Stent
  • Non-vascular Stent
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Care Centers (ACS)
  • Specialty Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. End Use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Covered Stent Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of vascular diseases
      • 3.2.1.2. Technological advancements in covered stent
      • 3.2.1.3. Increased awareness and diagnosis
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of covered stents
      • 3.2.2.2. Regulatory compliance
  • 3.3. Covered Stent Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Covered Stent Market: Product Estimates & Trend Analysis

  • 4.1. Covered Stent Market: Product Dashboard
  • 4.2. Covered Stent Market: Product Movement Analysis
  • 4.3. Covered Stent Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Vascular Stent
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Non-vascular Stent
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Covered Stent Market: End Use Estimates & Trend Analysis

  • 5.1. Covered Stent Market: End Use Dashboard
  • 5.2. Covered Stent Market: End Use Movement Analysis
  • 5.3. Covered Stent Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Care Centers (ACS)
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Specialty Clinics
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Covered Stent Market: Regional Estimates & Trend Analysis by Country, Product, & End Use

  • 6.1. Global Covered Stent Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Boston Scientific Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Biotronik SE & Co. KG
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. W. L. Gore & Associates, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Cook
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Terumo Corporation
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. B. Braun Interventional Systems, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BD
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Getinge
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives